Neurodegeneration-associated mutant TREM2 proteins abortively cycle between the ER and ER–Golgi intermediate compartment
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Triggering receptor expressed on myeloid cells 2 (TREM2) is a transmembrane protein expressed on microglia within the brain. Several rare mutations in TREM2 cause an early-onset form of neurodegeneration when inherited homozygously. Here we investigate how these mutations affect the intracellular transport of TREM2. We find that most pathogenic TREM2 mutant proteins fail to undergo normal maturation in the Golgi complex and show markedly reduced cell-surface expression. Prior research has suggested that two such mutants are retained in the endoplasmic reticulum (ER), but we find, using a cell-free coat protein complex II (COPII) vesicle budding reaction, that mutant TREM2 is exported efficiently from the ER. In addition, mutant TREM2 becomes sensitive to cleavage by endoglycosidase D under conditions that inhibit recycling to the ER, indicating that it normally reaches a post-ER compartment. Maturation-defective TREM2 mutants are also efficiently bound by a lectin that recognizes O-glycans added in the ER–Golgi intermediate compartment (ERGIC) and cis-Golgi cisterna. Finally, mutant TREM2 accumulates in the ERGIC in cells depleted of COPI. These results indicate that efficient ER export is not sufficient to enable normal cell-surface expression of TREM2. Moreover, our findings suggest that the ERGIC may play an underappreciated role as a quality-control center for mutant and/or malformed membrane proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 2×
“Triggering receptor expressed on myeloid cells 2 (TREM2) is a cell surface receptor of the innate immune system that is expressed on dendritic cells, macrophages, osteclasts and microglia (Bouchon et al., 2001; Colonna, 2003; Turnbull et al., 2006; Butovsky et al., 2014).”
BackgroundOne step at a time: endoplasmic reticulum-associated degradation
Vembar, S. S., & Brodsky, J. L. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2546 · Cited by 1,299 · cited 1×
“Proteins that are unable to properly fold within the ER are ultimately degraded via a pathway termed ER-associated degradation, which involves dislocation of the protein from the ER to the cytoplasm and degradation via the proteasome (Vembar and Brodsky, 2008; Brodsky, 2012).”
BackgroundBouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284 · cited 4×
“In this context, it should be noted that under physiological conditions, TREM2 is normally found in complex with the signaling adaptor protein DAP12 at the cell surface (Colonna, 2003), and DAP12 is not expressed in the cell lines we have used for most experiments in this study.”
BackgroundInfluentialYeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C., & Sheng, M. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.015 · Cited by 943 · cited 3×
“Recent work has focused on how the R47H variant alters the biochemical properties of TREM2 (Wang et al., 2015; Kober et al., 2016; Yeh et al., 2016), and evidence is emerging that this variant is associated with impaired ligand binding.”
BackgroundTREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Kleinberger, G., Yamanishi, Y., Suárez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009093 · Cited by 798 · cited 9×
“In addition, the steady-state localization of these mutants appears to be restricted to the ER (Kleinberger et al., 2014; Park et al., 2015).”
BackgroundMethodInfluentialTREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701
Cutting Edge: TREM-2 Attenuates Macrophage Activation
Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3520 · Cited by 688
Paloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342259 · Cited by 683 · cited 3×
“To further investigate and expand on these findings, we began by generating the six known missense mutations (Y38C, T66M, D86V, V126G, D134G, and K186N) implicated in NHD or early-onset FTD lacking the bone phenotype (Paloneva et al., 2002; Klünemann et al., 2005; Guerreiro et al., 2013a,c; Le Ber et al., 2014).”
BackgroundBouchon, A., Hernández-Munain, C., Cella, M., & Colonna, M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1111 · Cited by 460 · cited 1×
“Triggering receptor expressed on myeloid cells 2 (TREM2) is a cell surface receptor of the innate immune system that is expressed on dendritic cells, macrophages, osteclasts and microglia (Bouchon et al., 2001; Colonna, 2003; Turnbull et al., 2006; Butovsky et al., 2014).”
BackgroundHammond, C., & Helenius, A. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.1.41 · Cited by 443 · cited 3×
“In addition, the temperature-sensitive folding mutant of the vesicular stomatitis virus G protein (tsO45 VSV-G) can reach the early Golgi when over-expressed, and appears to recycle to the ER by remaining in complex with the KDELmotif containing ER chaperone, BiP (Hammond and Helenius, 1994).”
Background
Cited by
Distinct mechanisms of microRNA sorting into cancer cell-derived extracellular vesicle subtypes
Temoche-Diaz, M. M., Shurtleff, M. J., Nottingham, R. M., Yao, J., Fadadu, R. P., Lambowitz, A. M., & Schekman, R. (2019) · eLife · doi:10.7554/elife.47544 · Cited by 227
Self-citationDistinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities
Yao, H., Coppola, K., Schweig, J. E., Crawford, F., Mullan, M., & Paris, D. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00457 · Cited by 110
The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease
Bonham, L. W., Sirkis, D. W., & Yokoyama, J. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01170 · Cited by 83
Self-citationArchitecture and Dynamics of the Neuronal Secretory Network
Kennedy, M. J., & Hanus, C. (2019) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100818-125418 · Cited by 63
The needs of a synapse—How local organelles serve synaptic proteostasis
Grochowska, K. M., Andres‐Alonso, M., Karpova, A., & Kreutz, M. R. (2022) · The EMBO Journal · doi:10.15252/embj.2021110057 · Cited by 38
“…in the folding and quality control of nascent proteins but is also involved in O-and N-glycosylation, and in the synthesis of glycosaminoglycans and lipids (Krijnse-Locker et al , 1995; Jo¨nsson et al , 2003; Sannerud et al , 2006; Ge et al , 2013; Sirkis et al , 2017; Saraste & Marie, 2018).”
Metadata
- Authors
- Sirkis, D. W., Aparicio, R. E., & Schekman, R.
- Venue
- Molecular Biology of the Cell
- Published
- 2017-10
- Volume
- 28
- Issue
- 20
- Pages
- 2723-2733
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- OpenAlex
- W2642419157
- Cited by
- 41
- References
- 13
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurodegeneration-associated mutant TREM2 proteins abortively cycle between the ER and ER–Golgi intermediate compartment. https://app.cochat.ai/papers/10.1091/mbc.e17-06-0423
- The paper
- Sirkis, D. W., Aparicio, R. E., & Schekman, R. (2017). Neurodegeneration-associated mutant TREM2 proteins abortively cycle between the ER and ER–Golgi intermediate compartment. Molecular Biology of the Cell. https://doi.org/10.1091/mbc.e17-06-0423
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.